Stock DNA
Pharmaceuticals & Biotechnology
CNY 9,907 Million (Mid Cap)
139.00
NA
0.24%
-0.01
2.59%
2.27
Revenue and Profits:
Net Sales:
626 Million
(Quarterly Results - Mar 2026)
Net Profit:
35 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.11%
0%
-4.11%
6 Months
-16.08%
0%
-16.08%
1 Year
-12.06%
0%
-12.06%
2 Years
-5.57%
0%
-5.57%
3 Years
-13.46%
0%
-13.46%
4 Years
20.17%
0%
20.17%
5 Years
-31.57%
0%
-31.57%
Yantai Dongcheng Biochemicals Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-4.01%
EBIT Growth (5y)
-22.53%
EBIT to Interest (avg)
8.10
Debt to EBITDA (avg)
1.13
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
0.48
Tax Ratio
38.84%
Dividend Payout Ratio
35.89%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.52%
ROE (avg)
7.61%
Valuation key factors
Factor
Value
P/E Ratio
139
Industry P/E
Price to Book Value
2.80
EV to EBIT
73.79
EV to EBITDA
36.58
EV to Capital Employed
2.37
EV to Sales
4.99
PEG Ratio
NA
Dividend Yield
0.51%
ROCE (Latest)
3.21%
ROE (Latest)
2.02%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
626.40
698.00
-10.26%
Operating Profit (PBDIT) excl Other Income
83.20
143.70
-42.10%
Interest
36.50
43.80
-16.67%
Exceptional Items
0.20
0.20
Consolidate Net Profit
34.90
29.90
16.72%
Operating Profit Margin (Excl OI)
132.90%
125.00%
0.79%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -10.26% vs 5.85% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 16.72% vs -45.14% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
2,722.60
2,852.40
-4.55%
Operating Profit (PBDIT) excl Other Income
572.20
456.10
25.45%
Interest
138.90
98.20
41.45%
Exceptional Items
0.90
-84.70
101.06%
Consolidate Net Profit
154.40
141.40
9.19%
Operating Profit Margin (Excl OI)
129.40%
98.70%
3.07%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -4.55% vs -12.43% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 9.19% vs -44.37% in Dec 2024
About Yantai Dongcheng Biochemicals Co., Ltd. 
Yantai Dongcheng Biochemicals Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






